Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS) - Sturm, L; Bettinger, D; Giesler, M (United European Gastroenterol J, 2018)
et al.